Patent Yard Sign in
Expired Canadian patentCanada

Method and apparatus for treating vulnerable artherosclerotic plaque

CA 2504524 C · Owner: Parker, Theodore L. · Inventors: Litvack, Frank; Parker, Theodore L.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Methods and apparatus for treatment of vulnerable plaque provide local delivery of one or more plaque stabilizing agents. Delivery of the plaque stabilizing agents described herein stabilize vulnerable plaques at and downstream of an implantation site can reduce the occurrence of rupture of these plaques. An expandable medical device for delivering a therapeutic agent locally to a vulnerable plaque includes an implantable medical device body configured to be implanted within a coronary artery and a therapeutic dosage , of a therapeutic agent for stabilization of vulnerable plaque. The therapeutic agent is affixed in openings in the implantable medical device body in a manner such …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed November 10, 2003 and granted October 10, 2017. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 10, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 10, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 10, 2003
GrantedOctober 10, 2017
Term endedNovember 10, 2023
Patent numberCA 2504524 C
Classification (IPC)A61L31/16 +2 more

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedNov 10, 2003Patent grantedOct 10, 2017Term endedNov 10, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.